Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Safety Run-In Part: M7824 + Gemcitabine + Cisplatin	12
Overall Study	STARTED	Double-blinded Part: Placebo + Gemcitabine + Cisplatin	149
Overall Study	STARTED	Double-blinded Part: M7824 + Gemcitabine + Cisplatin	148
Overall Study	Treated	Safety Run-In Part: M7824 + Gemcitabine + Cisplatin	12
Overall Study	Treated	Double-blinded Part: Placebo + Gemcitabine + Cisplatin	149
Overall Study	Treated	Double-blinded Part: M7824 + Gemcitabine + Cisplatin	146
Overall Study	COMPLETED	Safety Run-In Part: M7824 + Gemcitabine + Cisplatin	12
Overall Study	COMPLETED	Double-blinded Part: Placebo + Gemcitabine + Cisplatin	149
Overall Study	COMPLETED	Double-blinded Part: M7824 + Gemcitabine + Cisplatin	146
Overall Study	NOT COMPLETED	Safety Run-In Part: M7824 + Gemcitabine + Cisplatin	0
Overall Study	NOT COMPLETED	Double-blinded Part: Placebo + Gemcitabine + Cisplatin	0
Overall Study	NOT COMPLETED	Double-blinded Part: M7824 + Gemcitabine + Cisplatin	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04066491/flow